Background. Gestational diabetes (GDM) affects up to 7% of pregnant women and is associated with several maternal and perinatal morbidities. International organizations suggest several different recommendations regarding how to screen and to manage GDM. Objective. We aimed to analyze the most important and employed guidelines about screening and management of GDM and we investigated existing related literature. Results. We found several different criteria for screening for GDM, for monitoring GDM, and for starting pharmacological therapy. When using IADPSG criteria, GDM rate increased, perinatal outcomes improved, and screening became cost-effective. Compared to no treatment, treatment of women meeting criteria for GDM by IADPSG criteria but not by other less strict criteria has limited evidence for an effect on adverse pregnancy outcomes.
Recommended CitationCaissutti, Claudia and Berghella, Vincenzo, "Scientific Evidence for Different Options for GDM Screening and Management: Controversies and Review of the Literature." (2017). Department of Obstetrics and Gynecology Faculty Papers. Paper 43.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.